← ANALYST RATINGS · TIPRANKS
Alector (ALEC): analyst forecast and price target
Analyst consensus
Hold2 Buy3 Hold1 Sell
Ratings of 6 analysts in the last 3 months · top analysts only12-month forecast
Based on 6 price targets given in the last 3 months, the average target is $4.62, the highest $8.00, the lowest $1.50. The average is +151.4% from the last price of $1.84.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $1.50 → $2.00+33.3% | Hold | +8.7% | Reiterated | 16.10.26on TipRanks 19:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $1.50 → $2.00+33.3% | Hold | +8.7% | Reiterated | 16.10.26on TipRanks 19:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1.50 → $2.00+33.3% | Hold | +8.7% | Upgrade | 16.10.26on TipRanks 18:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $1.50 → $2.00+33.3% | Hold | +8.7% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $1.50 → $2.00+33.3% | Hold | +8.7% | Reiterated | 16.10.26on TipRanks 18:05 | — | |
| Andrew Fein★★★★★★★★★★#267 · hits 52% · avg +23.7% | H.C. Wainwright | $5.00 → $8.00+60.0% | Buy | +334.8% | Reiterated | 14.10.26on TipRanks 11:55 | +1.6%next day +1.3% | ↗ |
| Alec Stranahan★★★★★★★★★★#1533 · hits 52% · avg +8.4% | Bank of America Securities | $1.00 | Sell | −45.7% | Reiterated | 14.10.26on TipRanks 06:45 | +1.6%next day +1.3% | ↗ |
| Sean Laaman★★★★★★★★★★#446 · hits 67% · avg +17.2% | Morgan Stanley | $3.00 | Sell | +63.0% | Reiterated | 14.10.26on TipRanks 06:35 | +1.6%next day +1.3% | ↗ |
| Thomas Shrader★★★★★★★★★★#2198 · hits 39% · avg +6.6% | BTIG | $6.00 | Buy | +226.1% | Reiterated | 13.10.26on TipRanks Oct 14 06:15 | −10.1%next day +1.6% | ↗ |
| Graig Suvannavejh★★★★★★★★★★#381 · hits 48% · avg +21.6% | Mizuho Securities | $1.50 | Hold | −18.5% | Reiterated | 06.10.26on TipRanks Oct 7 05:20 | −9.6%next day +6.3% · 5 days +3.5% | ↗ |
| Yaron Werber★★★★★★★★★★#117 · hits 59% · avg +28.0% | TD Cowen | — | Hold | — | Reiterated | 05.10.26on TipRanks 10:11 | +9.3%next day −9.6% · 5 days +4.1% | ↗ |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $2.00 | Hold | +8.7% | Reiterated | 30.09.26on TipRanks Sep 29 23:05 | — | |
| Myles Minter★★★★★★★★★★#92 · hits 61% · avg +34.9% | William Blair | — | Hold | — | Reiterated | 07.08.26on TipRanks 03:50 | −3.3%next day −5.0% · 5 days +9.7% | ↗ |
| Pete Stavropoulos★★★★★★★★★★#2065 · hits 45% · avg +16.4% | Cantor Fitzgerald | — | Buy | — | Upgrade | 15.04.26on TipRanks 07:05 | +6.3%next day −1.4% · 5 days −6.6% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Alector
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $2.38 at a price of $1.85 (+28.4%); now: $3.90 at $1.84 (+112.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 1 | 1 | 5 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 6 | 5 | 4 | 3 | 4 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 3 |
Earnings and sales forecast
Next report: 10.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.22 (from $-0.24 to $-0.19). Last quarter: $-0.21.
Sales
Next quarter’s sales estimate — $2M (from $0M to $5M). Last quarter: $3M.
Best top-analyst consensus in the sector · Healthcare
About Alector
- CEO: Arnon Rosenthal
- Employees: 103
- 131 Oyster Point Boulevard, South San Francisco, CA, 94080, US
- www.alector.com
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Data from the stock’s TipRanks forecast page, read 34 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗